British shares moved lower through Friday trading, with the blue-chip FTSE 100 losing ground as geopolitical concerns and softer domestic data weighed on sentiment. At 12:25 GMT the FTSE 100 was down 0.4%. The pound also weakened, with GBP/USD falling 0.4% to 1.3281.
Across continental Europe, Germany's DAX fell 1.3% and France's CAC 40 dropped 0.8% as investors reacted to the same risk-off tone sweeping markets.
Economic data and policy updates
Official figures released on Friday showed that UK retail sales volumes decreased by 0.4% month-on-month in February 2026, a smaller fall than the consensus forecast which expected a 0.7% decline. The February contraction followed a revised 2.0% month-on-month increase in January, which had previously been reported as 1.8%. The decline in February was broad-based, affecting five of the seven main retail categories tracked by the Office for National Statistics.
Also on Friday, the Bank of England announced changes to the pricing of its Discount Window Facility. The central bank said it would lower and fix the pricing of that facility to reinforce its role as an accessible, on-demand liquidity tool. The Bank described the adjustments as measures intended to support firms' liquidity management while preserving incentives for prudent day-to-day operations.
Corporate movers
AstraZeneca PLC (AZN) stock rose 2.8% after the company reported that tozorakimab met its primary endpoint in two Phase III clinical trials for chronic obstructive pulmonary disease. The company disclosed positive outcomes from the OBERON and TITANIA trials on Thursday, noting that tozorakimab reduced the annualized rate of moderate-to-severe COPD exacerbations compared with placebo in the primary population of former smokers and in the overall population.
Shares in Harbour Energy PLC (HBR) fell more than 5% after Germany's BASF sold 80 million shares in the British oil producer at 273 pence apiece. The placing price represented a 9% discount to the previous close. Harbour Energy will not receive any proceeds from the sale. During the session the FTSE-listed company's shares traded at 284.4 pence, recovering from an intraday low of 273.25 pence, which matched the placing price.
Key takeaways
- Market sentiment was pressured by ongoing Middle East tensions, contributing to declines in UK and wider European equities.
- UK retail sales volumes fell 0.4% month-on-month in February, a broad-based decline across several retail categories.
- Company-specific developments drove stock moves: AstraZeneca rallied after positive Phase III COPD trial results, while Harbour Energy slid after BASF's discounted share placement.
Risks and uncertainties
- Geopolitical tensions in the Middle East - risk to investor sentiment and equity valuations across sectors.
- Softening consumer spending as indicated by the decline in retail sales - risk to consumer-facing sectors and retail revenues.
- Large block share sales that do not benefit the issuer, such as the BASF placement in Harbour Energy - risk to the producer's share price and market perception in the energy sector.
These developments underline a cautious market environment where macro risks, policy adjustments to liquidity tools, and company-specific announcements all interact to influence prices across equities and foreign exchange.